BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Dou YX, Zhou JT, Wang TT, Huang YF, Chen VP, Xie YL, Lin ZX, Gao JS, Su ZR, Zeng HF. Self-nanoemulsifying drug delivery system of bruceine D: a new approach for anti-ulcerative colitis. Int J Nanomedicine 2018;13:5887-907. [PMID: 30319255 DOI: 10.2147/IJN.S174146] [Cited by in Crossref: 21] [Cited by in F6Publishing: 12] [Article Influence: 5.3] [Reference Citation Analysis]
Number Citing Articles
1 Singh N, Handa M, Singh V, Kesharwani P, Shukla R. Lymphatic targeting for therapeutic application using nanoparticulate systems. J Drug Target 2022;:1-34. [PMID: 35722764 DOI: 10.1080/1061186X.2022.2092741] [Reference Citation Analysis]
2 Zhang J, Xu H, Dou Y, Huang Q, Xian Y, Lin Z. Major Constituents From Brucea javanica and Their Pharmacological Actions. Front Pharmacol 2022;13:853119. [DOI: 10.3389/fphar.2022.853119] [Reference Citation Analysis]
3 Qu C, Li QP, Su ZR, Ip SP, Yuan QJ, Xie YL, Xu QQ, Yang W, Huang YF, Xian YF, Lin ZX. Nano-Honokiol ameliorates the cognitive deficits in TgCRND8 mice of Alzheimer's disease via inhibiting neuropathology and modulating gut microbiota. J Adv Res 2022;35:231-43. [PMID: 35024199 DOI: 10.1016/j.jare.2021.03.012] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Sin ZW, Bhardwaj V, Pandey AK, Garg M. A brief overview of antitumoral actions of bruceine D. Exploration of Targeted Anti-tumor Therapy 2020;1:200-17. [DOI: 10.37349/etat.2020.00013] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
5 Wang S, Hu H, Zhong B, Shi D, Qing X, Cheng C, Deng X, Zhang Z, Shao Z. Bruceine D inhibits tumor growth and stem cell-like traits of osteosarcoma through inhibition of STAT3 signaling pathway. Cancer Med 2019;8:7345-58. [PMID: 31631559 DOI: 10.1002/cam4.2612] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 4.7] [Reference Citation Analysis]
6 Alhasani KF, Kazi M, Ibrahim MA, Shahba AA, Alanazi FK. Self-nanoemulsifying ramipril tablets: a novel delivery system for the enhancement of drug dissolution and stability. Int J Nanomedicine 2019;14:5435-48. [PMID: 31409997 DOI: 10.2147/IJN.S203311] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
7 Gao C, Liu L, Zhou Y, Bian Z, Wang S, Wang Y. Novel drug delivery systems of Chinese medicine for the treatment of inflammatory bowel disease. Chin Med 2019;14:23. [PMID: 31236131 DOI: 10.1186/s13020-019-0245-x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 4.7] [Reference Citation Analysis]
8 Yoon BK, Lim ZY, Jeon WY, Cho NJ, Kim JH, Jackman JA. Medicinal Activities and Nanomedicine Delivery Strategies for Brucea javanica Oil and Its Molecular Components. Molecules 2020;25:E5414. [PMID: 33228061 DOI: 10.3390/molecules25225414] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
9 Teruel AH, Gonzalez-Alvarez I, Bermejo M, Merino V, Marcos MD, Sancenon F, Gonzalez-Alvarez M, Martinez-Mañez R. New Insights of Oral Colonic Drug Delivery Systems for Inflammatory Bowel Disease Therapy. Int J Mol Sci 2020;21:E6502. [PMID: 32899548 DOI: 10.3390/ijms21186502] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 4.5] [Reference Citation Analysis]
10 Plaza-Oliver M, Santander-Ortega MJ, Lozano MV. Current approaches in lipid-based nanocarriers for oral drug delivery. Drug Deliv Transl Res 2021;11:471-97. [PMID: 33528830 DOI: 10.1007/s13346-021-00908-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
11 Kulkarni VR, Kazi M, Shahba AA, Radhanpuri A, Maniruzzaman M. Three-Dimensional Printing of a Container Tablet: A New Paradigm for Multi-Drug-Containing Bioactive Self-Nanoemulsifying Drug-Delivery Systems (Bio-SNEDDSs). Pharmaceutics 2022;14:1082. [DOI: 10.3390/pharmaceutics14051082] [Reference Citation Analysis]
12 Liu Y, Li BG, Su YH, Zhao RX, Song P, Li H, Cui XH, Gao HM, Zhai RX, Fu XJ, Ren X. Potential activity of Traditional Chinese Medicine against Ulcerative colitis: A review. J Ethnopharmacol 2022;:115084. [PMID: 35134488 DOI: 10.1016/j.jep.2022.115084] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Zheng X, Mai L, Wang T, Xu Y, Su Z, Chen J, Zeng H, Xie Y. Brusatol-Enriched Brucea javanica Oil Ameliorated Dextran Sulfate Sodium-Induced Colitis in Mice: Involvement of NF-κB and RhoA/ROCK Signaling Pathways. Biomed Res Int 2021;2021:5561221. [PMID: 34414236 DOI: 10.1155/2021/5561221] [Reference Citation Analysis]
14 Akhtar N, Mohammed SA, Khan RA, Yusuf M, Singh V, Mohammed HA, Al-omar MS, Abdellatif AA, Naz M, Khadri H. Self-Generating nano-emulsification techniques for alternatively-routed, bioavailability enhanced delivery, especially for anti-cancers, anti-diabetics, and miscellaneous drugs of natural, and synthetic origins. Journal of Drug Delivery Science and Technology 2020;58:101808. [DOI: 10.1016/j.jddst.2020.101808] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
15 Jianxian C, Saleem K, Ijaz M, Ur-Rehman M, Murtaza G, Asim MH. Development and in vitro Evaluation of Gastro-protective Aceclofenac-loaded Self-emulsifying Drug Delivery System. Int J Nanomedicine 2020;15:5217-26. [PMID: 32801687 DOI: 10.2147/IJN.S250242] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
16 Buya AB, Beloqui A, Memvanga PB, Préat V. Self-Nano-Emulsifying Drug-Delivery Systems: From the Development to the Current Applications and Challenges in Oral Drug Delivery. Pharmaceutics 2020;12:E1194. [PMID: 33317067 DOI: 10.3390/pharmaceutics12121194] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
17 Min X, Guo Y, Zhou Y, Chen X. Protection against Dextran Sulfate Sodium-Induced Ulcerative Colitis in Mice by Neferine, A Natural Product from Nelumbo nucifera Gaertn. Cell J 2021;22:523-31. [PMID: 32347046 DOI: 10.22074/cellj.2021.6918] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
18 Luo C, Wang Y, Wei C, Chen Y, Ji Z. The anti-migration and anti-invasion effects of Bruceine D in human triple-negative breast cancer MDA-MB-231 cells. Exp Ther Med 2020;19:273-9. [PMID: 31853299 DOI: 10.3892/etm.2019.8187] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
19 Wei W, Zhang Y, Li R, Cao Y, Yan X, Ma Y, Zhang Y, Yang M, Zhang M. Oral Delivery of Pterostilbene by L-Arginine-Mediated “Nano-Bomb” Carrier for the Treatment of Ulcerative Colitis. IJN 2022;Volume 17:603-16. [DOI: 10.2147/ijn.s347506] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
20 Hosny KM, Al Nahyah KS, Alhakamy NA. Self-Nanoemulsion Loaded with a Combination of Isotretinoin, an Anti-Acne Drug, and Quercetin: Preparation, Optimization, and In Vivo Assessment. Pharmaceutics 2020;13:46. [PMID: 33396942 DOI: 10.3390/pharmaceutics13010046] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
21 Vishwakarma N, Jain A, Sharma R, Mody N, Vyas S, Vyas SP. Lipid-Based Nanocarriers for Lymphatic Transportation. AAPS PharmSciTech 2019;20:83. [PMID: 30673895 DOI: 10.1208/s12249-019-1293-3] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 9.0] [Reference Citation Analysis]